SPCs demystified in our next webinar

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

SPCs demystified in our next webinar

Our next webinar on June 23 will discuss the latest developments regarding supplementary protection certificates (SPCs) in Europe

Drugs

The SPC regime, which dates back to 1992, has the relatively straightforward and uncontroversial purpose of extending protection for pharmaceutical (and some other) products whose launch is delayed by the regulatory process.

However, its application in practice has been complex, with many cases generating questions over the definition, scope and term of SPCs, as well as their application in different EU member states.

Continuing uncertainty

Because the regime is based on an EU Regulation, national courts have had to refer many of these questions to the Court of Justice of the EU in the hope of getting a clear ruling. Unfortunately, that hope has not always been fulfilled, leading to continuing uncertainty for many in the industry.

EU flag

Our webinar on June 23, which starts at 5pm London time, will feature Mike Gilbert and Angus Fairbairn of specialist IP firm Marks & Clerk and Dr Jocelyn Man of Gilead Sciences, and I will be moderating it.

The speakers will briefly set out the background to the SPC regime, before discussing the latest decisions from the CJEU and other open issues. These include questions such as: what does “protected by a basic patent” mean? And what is “active ingredient”? Jocelyn will also be able to provide a perspective from industry on the value of SPCs and the kinds of issues that pharma companies face.

In an industry where sales of blockbuster products can be counted in the millions of dollars per day, understanding the latest law on SPCs is vital for both originator and generic companies, so I’m sure this webinar will be of interest to all those in the industry around the world, as well as those who advise them in Europe and elsewhere.

Like all our webinars, you can easily view and listen from your desk (or anywhere with an internet connection) and there will be opportunities to ask questions of the speakers too. The webinar will last about one hour and if you can’t make next Tuesday, you can listen again at any convenient time. Registration is free, but must be done in advance.

more from across site and SHARED ros bottom lb

More from across our site

Two experienced UPC practitioners join the UK IP boutique’s growing German operation, with further recruitment planned as the firm expands in Europe
The Australian IP firm is taking on bigger rivals in Southeast Asia, betting that agility and transparent pricing can help it stand out
The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
Gift this article